Cardinal Health, Inc. (NYSE:CAH) has been assigned a $70.00 price target by investment analysts at Mizuho in a research note issued on Tuesday. The brokerage presently has a “hold” rating on the stock. Mizuho’s target price indicates a potential upside of 5.36% from the stock’s previous close.

Other research analysts have also recently issued research reports about the company. Zacks Investment Research cut Cardinal Health from a “hold” rating to a “sell” rating in a research note on Tuesday, July 4th. Evercore ISI reaffirmed an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, July 4th. BidaskClub cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 11th. Credit Suisse Group reaffirmed an “outperform” rating and set a $87.00 target price (up previously from $81.00) on shares of Cardinal Health in a research note on Thursday, July 13th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $77.00 target price on shares of Cardinal Health in a research note on Thursday, July 27th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and five have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $75.72.

Cardinal Health (NYSE:CAH) opened at 66.44 on Tuesday. The stock’s 50 day moving average price is $67.02 and its 200 day moving average price is $71.93. The company has a market capitalization of $21.03 billion, a price-to-earnings ratio of 16.49 and a beta of 0.86. Cardinal Health has a 12 month low of $62.70 and a 12 month high of $84.88.

Cardinal Health (NYSE:CAH) last issued its earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.24 by $0.07. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The firm had revenue of $32.97 billion for the quarter, compared to analysts’ expectations of $32.73 billion. During the same period in the previous year, the firm posted $1.14 earnings per share. The business’s revenue was up 5.0% compared to the same quarter last year. Equities research analysts anticipate that Cardinal Health will post $4.95 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was published by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/10/25/cardinal-health-inc-cah-pt-set-at-70-00-by-mizuho.html.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CAH. Massmutual Trust Co. FSB ADV acquired a new stake in Cardinal Health during the 4th quarter worth about $101,000. Acrospire Investment Management LLC acquired a new stake in Cardinal Health during the 1st quarter worth about $107,000. Integrated Investment Consultants LLC grew its position in Cardinal Health by 15.4% during the 2nd quarter. Integrated Investment Consultants LLC now owns 1,459 shares of the company’s stock worth $114,000 after purchasing an additional 195 shares during the period. Advisory Services Network LLC acquired a new stake in Cardinal Health during the 1st quarter worth about $120,000. Finally, Bronfman E.L. Rothschild L.P. grew its position in Cardinal Health by 31.8% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock worth $123,000 after purchasing an additional 382 shares during the period. 87.80% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.